Diffusion Pharmaceuticals (DFFN) Says First Patient Dosed in Phase 3 Trial with TSC in Inoperable Glioblastoma Multiforme Jan 29, 2018 04:01PM
Diffusion Pharmaceuticals Announces First Patient Dosed in Phase 3 Trial with TSC in Inoperable Glioblastoma Multiforme Jan 29, 2018 04:00PM
Diffusion Pharmaceuticals (DFFN) Commences Phase 3 Clinical Trial with TSC in Glioblastoma Multiforme Dec 27, 2017 08:03AM
Diffusion Pharmaceuticals Begins Phase 3 Clinical Trial with TSC in Glioblastoma Multiforme Dec 27, 2017 08:00AM